how long should you be on a glp 1 The biomarkers to watch when you're GLP-1 GLP-1 Diet: Understanding How GLP-1

Int J Pharm Sci Rev Res

Furthermore, treatment of T2D and obesity with metabolic surgery, which results in increased GLP-1 secretion (98), has been associated with an increased risk of suicide and self-harm (99), hinting to a potential causal relationship

Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen requirements

Prolactin stays minimal throughout

The big picture: Mounjaro, Ozempic and Wegovy are all part of a buzzy class of drugs known as GLP-1 agonists, which are seen as potential game-changers for patients struggling with obesity and diabetes and are at risk for heart attack and stroke